These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31740386)

  • 1. Kidney-secreted erythropoietin lowers lipidemia via activating JAK2-STAT5 signaling in adipose tissue.
    Li J; Yang M; Yu Z; Tian J; Du S; Ding H
    EBioMedicine; 2019 Dec; 50():317-328. PubMed ID: 31740386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.
    Landau D; London L; Bandach I; Segev Y
    PLoS One; 2018; 13(5):e0196684. PubMed ID: 29738538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin induces sustained phosphorylation of STAT5 in primitive but not definitive erythrocytes generated from mouse embryonic stem cells.
    Tsuji-Takayama K; Otani T; Inoue T; Nakamura S; Motoda R; Kibata M; Orita K
    Exp Hematol; 2006 Oct; 34(10):1323-32. PubMed ID: 16982325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin.
    Byts N; Samoylenko A; Fasshauer T; Ivanisevic M; Hennighausen L; Ehrenreich H; Sirén AL
    Cell Death Differ; 2008 Apr; 15(4):783-92. PubMed ID: 18259195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin Rescues Memory Impairment in a Rat Model of Chronic Cerebral Hypoperfusion via the EPO-R/JAK2/STAT5/PI3K/Akt/GSK-3β Pathway.
    Ma S; Chen J; Chen C; Wei N; Xu J; Yang G; Wang N; Meng Y; Ren J; Xu Z
    Mol Neurobiol; 2018 Apr; 55(4):3290-3299. PubMed ID: 28488208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin induces miRNA-210 by JAK2/STAT5 signaling in PBMCs of End-stage Renal Disease patients.
    Felaco P; Felaco M; Franceschelli S; Ferrone A; Gatta DMP; Speranza L; Patruno A; De Lutiis MA; Ballerini P; Sirolli V; Grilli A; Bonomini M; Pesce M
    FEBS J; 2020 Dec; 287(23):5167-5182. PubMed ID: 32196922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence for protective erythropoietin alpha signalling in rat hepatocytes.
    Bramey T; Freitag P; Fandrey J; Rauen U; Pamp K; Erhard J; Frede S; de Groot H; Petrat F
    BMC Gastroenterol; 2009 Apr; 9():26. PubMed ID: 19383129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-Regulation of Cardiac Erythropoietin Receptor and its Downstream Activated Signal Transducer Phospho-STAT-5 in a Rat Model of Chronic Kidney Disease.
    Hertzberg-Bigelman E; Barashi R; Levy R; Cohen L; Ben-Shoshan J; Keren G; Entin-Meer M
    Isr Med Assoc J; 2016 Jun; 18(6):326-30. PubMed ID: 27468524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of supplemental erythropoietin on its receptor expression and signal transduction pathways in rat model of retinal detachment.
    Xie Z; Chen F; Wu X; Zhuang C; Zhu J; Wang J; Ji H; Wang Y; Hua X
    Curr Eye Res; 2012 Feb; 37(2):138-44. PubMed ID: 22251399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cells.
    Breggia AC; Wojchowski DM; Himmelfarb J
    Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1689-95. PubMed ID: 18815218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
    Arcasoy MO; Harris KW; Forget BG
    Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury.
    Salahudeen AK; Haider N; Jenkins J; Joshi M; Patel H; Huang H; Yang M; Zhe H
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1354-65. PubMed ID: 18385271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic intermittent hypobaric hypoxia improves iron metabolism disorders via the IL-6/JAK2/STAT3 and Epo/STAT5/ERFE signaling pathways in metabolic syndrome rats.
    Cui F; Sun J; Mi H; Li B; Tang L; Wang R; Du Y; Guo B; Li Y; Shi M
    J Trace Elem Med Biol; 2023 Sep; 79():127259. PubMed ID: 37413927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palmitate deranges erythropoietin production via transcription factor ATF4 activation of unfolded protein response.
    Anusornvongchai T; Nangaku M; Jao TM; Wu CH; Ishimoto Y; Maekawa H; Tanaka T; Shimizu A; Yamamoto M; Suzuki N; Sassa R; Inagi R
    Kidney Int; 2018 Sep; 94(3):536-550. PubMed ID: 29887316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of angelica polysaccharides co-erythropoietin on JAK2/STAT5 signal transduction pathway in hematopoietic stem/progenitor cells].
    Hua Z; Song S; Luo C; Wang J; Wang Y
    Zhongguo Zhong Yao Za Zhi; 2009 Dec; 34(24):3268-71. PubMed ID: 20353016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin Ameliorates Lung Injury by Accelerating Pulmonary Endothelium Cell Proliferation via Janus Kinase-Signal Transducer and Activator of Transcription 3 Pathway After Kidney Ischemia and Reperfusion Injury.
    Zhu M; Wang L; Yang J; Xie K; Zhu M; Liu S; Xu C; Wang J; Gu L; Ni Z; Xu G; Che M
    Transplant Proc; 2019 Apr; 51(3):972-978. PubMed ID: 30979490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin ameliorates early brain injury after subarachnoid haemorrhage by modulating microglia polarization via the EPOR/JAK2-STAT3 pathway.
    Wei S; Luo C; Yu S; Gao J; Liu C; Wei Z; Zhang Z; Wei L; Yi B
    Exp Cell Res; 2017 Dec; 361(2):342-352. PubMed ID: 29102603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection.
    Hu MC; Shi M; Cho HJ; Zhang J; Pavlenco A; Liu S; Sidhu S; Huang LJ; Moe OW
    Kidney Int; 2013 Sep; 84(3):468-81. PubMed ID: 23636173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
    Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
    Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.